Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

593.25 -4.53 (-0.76%)
Official Closing Price Updated: 7:00 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
30 31 Next >
News headline image
Top S&P500 movers in Thursday's session ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday. 
Via Chartmill
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript ↗
TMO earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beat ↗
Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts. 
Via Investor's Business Daily
News headline image
Smart Money Is Betting Big In TMO Options ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Unusual Options Activity For January 21 ↗
 
Via Benzinga
News headline image
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Thermo Fisher Scientific? ↗
 
Via Benzinga
News headline image
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands ↗
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased. 
Via Benzinga
Topics Earnings
News headline image
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
9 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Check Out What Whales Are Doing With TMO ↗
 
Via Benzinga
News headline image
Earnings Scheduled For January 30, 2025 ↗
 
Via Benzinga
News headline image
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass ↗
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI). 
Via Benzinga
Topics Artificial Intelligence
News headline image
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely. 
Via Benzinga
News headline image
Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch. 
Via MarketBeat
News headline image
Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
News headline image
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Completes $1B Share Repurchase
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific ↗
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results. 
Via Benzinga
News headline image
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test 
Via News Direct
News headline image
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
The Oncology Bet Is Already Paying Off For Pfizer ↗
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%... 
Via Benzinga
News headline image
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening 
Via News Direct
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.